LUNG NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated drug tested to supercharge cancer treatment
Disease control TerminatedThis early safety study tested whether a special light-activated drug (photodynamic therapy) given during surgery could help the body's immune system fight advanced lung cancer more effectively when combined with immunotherapy. The trial enrolled 5 patients with non-small cell lu…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Radiation 'Grid' tried to reboot failed cancer drug
Disease control TerminatedThis small, early-stage study tested if a special, targeted radiation technique called 'grid therapy' could help the immunotherapy drug durvalumab work again for patients with non-small cell lung cancer. The patients had already tried durvalumab, but their cancer started growing …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC